ASKA Pharmaceutical Holdings CO., Ltd.
4886あすか製薬ホールディングス株式会社
Latest half-year results
First half · fiscal year to 2026-03 · filed 2025-11-07For the first half of the fiscal year to 2026-03: Revenue ¥35.3 billion (+8.9% YoY), Ordinary income ¥2.7 billion (-19.7% YoY), Net income ¥2.2 billion (-13.0% YoY).
| This period | Year on year | |
|---|---|---|
| Revenue | ¥35.3bn | +8.9% |
| Ordinary profit | ¥2.7bn | -19.7% |
| Net profit to owners | ¥2.2bn | -13.0% |
From the securities report on EDINET, which states no forecast. History via /v1/companies/4886/earnings-releases.
Financials
Japan GAAP · consolidated · fiscal year to 2026-03-31- Revenue
- ¥71.1bn
- Net income
- ¥5.4bn
- ROE
- 8.0%
- Equity ratio
- 62.6%
- Dividend / share
- ¥60
- Employees
- 1,611
| Fiscal year | Revenue | Net income | Total assets | Net assets | ROE | EPS | Operating CF |
|---|---|---|---|---|---|---|---|
| 2026-03-31 | ¥71.1bn | ¥5.4bn | ¥112.4bn | ¥76.8bn | 8.0% | ¥191.12 | ¥6.3bn |
| 2025-03-31 | ¥64.1bn | ¥5.1bn | ¥104.3bn | ¥71.8bn | 8.0% | ¥179.95 | ¥2.5bn |
| 2024-03-31 | ¥62.8bn | ¥7.5bn | ¥90.7bn | ¥61.9bn | 13.0% | ¥266.51 | ¥1.5bn |
| 2023-03-31 | ¥60.5bn | ¥4.2bn | ¥87.1bn | ¥54.5bn | 8.2% | ¥150.08 | ¥3.4bn |
| 2022-03-31 | ¥56.6bn | ¥4.3bn | ¥83.3bn | ¥48.9bn | 8.8% | ¥151.22 | ¥2.8bn |
Indicators
Computed by us from filings · fiscal year to 2026-03-31| Metric | Value | Percentile among listed companies |
|---|---|---|
| ROE, % | 8 | 45.5 |
| Ordinary margin | 0.0796 | 56.9 |
| Equity ratio, % | 62.61 | 62.4 |
| Revenue growth | 0.109 | 71.6 |
| Net income growth | 0.0633 | 42.4 |
| Operating cash flow / assets | 0.0561 | 44.6 |
Results wording balance: +0.86. Proprietary text method; it describes the wording only and does not interpret context.
Interest example: if all ¥11.4bn of reported debt repriced by 50 basis points, a year's interest would rise by ¥57m, 0.9% of operating cash flow. Our arithmetic only, not a forecast: fixed-rate debt and hedges are ignored.
Via /v1/companies/4886/indicators. Descriptive figures, not a rating and not investment advice.
From other filings
As the company states themSegments, votes and tender offers
Stated in EDINET filings/v1/companies/4886/segments/v1/companies/4886/votingOwnership changes
All companies →- 2026-04-08
NIPPON ACTIVE VALUE FUND PLC raised holdings in ASKA Pharmaceutical Holdings CO., Ltd. (4886) to 21.32% from 20.49%.
- 2025-05-13
NIPPON ACTIVE VALUE FUND PLC raised holdings in ASKA Pharmaceutical Holdings CO., Ltd. (4886) to 20.49% from 19.43%.
- 2025-05-13
Holdings of NIPPON ACTIVE VALUE FUND PLC in ASKA Pharmaceutical Holdings CO., Ltd. (4886) moved above 20% (19.43% -> 20.49%).
- 2025-03-28
NIPPON ACTIVE VALUE FUND PLC raised holdings in ASKA Pharmaceutical Holdings CO., Ltd. (4886) to 19.43% from 17.94%.
- 2025-03-05
NIPPON ACTIVE VALUE FUND PLC raised holdings in ASKA Pharmaceutical Holdings CO., Ltd. (4886) to 17.94% from 16.92%.
- 2025-01-30
NIPPON ACTIVE VALUE FUND PLC raised holdings in ASKA Pharmaceutical Holdings CO., Ltd. (4886) to 16.92% from 15.89%.
- 2025-01-10
NIPPON ACTIVE VALUE FUND PLC raised holdings in ASKA Pharmaceutical Holdings CO., Ltd. (4886) to 15.89% from 14.90%.
- 2024-12-05
NIPPON ACTIVE VALUE FUND PLC raised holdings in ASKA Pharmaceutical Holdings CO., Ltd. (4886) to 14.90% from 13.88%.
- 2024-12-02
NIPPON ACTIVE VALUE FUND PLC raised holdings in ASKA Pharmaceutical Holdings CO., Ltd. (4886) to 13.88% from 12.82%.
- 2024-11-07
NIPPON ACTIVE VALUE FUND PLC raised holdings in ASKA Pharmaceutical Holdings CO., Ltd. (4886) to 12.82% from 11.82%.
Trades by 5% holders
From the 60-day trade tables in 5% reports| Holder | Period | Net shares | Net % of shares | Avg. filed price | Range |
|---|---|---|---|---|---|
| NAVF Select LLC | 2023-09-19 – 2025-05-02 | +575,000 | +1.74pt | ¥2,109.27 | ¥1,928–2,386 |
| Dalton Investments, Inc. | 2023-12-31 – 2025-05-02 | +2,382,000 | +7.91pt | ¥2,112.54 | ¥1,928–2,386 |
| NIPPON ACTIVE VALUE FUND PLC | 2023-09-19 – 2025-04-14 | +1,920,600 | +6.25pt | ¥2,086.94 | ¥1,928–2,386 |
| Dalton Investments LLC | 2023-09-19 – 2023-12-31 | -101,500 | −0.35pt | — | — |
| ゼリア新薬工業株式会社 | 2022-05-13 – 2022-06-07 | +42,900 | +0.11pt | — | — |
Net shares and the average are our calculations. Prices are filed prices as stated by the filer, mostly for off-market trades; they are not market prices. Stock lending, custody transfers and option exercises are excluded from net shares. Every row via /v1/companies/4886/trades.
5% filings
Large shareholding reports on 4886| Filed | Filer | Stake | Change | Stated purpose |
|---|---|---|---|---|
| 2026-04-08 | NIPPON ACTIVE VALUE FUND PLC | 21.32% | +0.83pt | may make proposals |
| 2025-05-13 | NIPPON ACTIVE VALUE FUND PLC | 20.49% | +1.06pt | may make proposals |
| 2025-03-28 | NIPPON ACTIVE VALUE FUND PLC | 19.43% | +1.49pt | may make proposals |
| 2025-03-05 | NIPPON ACTIVE VALUE FUND PLC | 17.94% | +1.02pt | may make proposals |
| 2025-01-30 | NIPPON ACTIVE VALUE FUND PLC | 16.92% | +1.03pt | may make proposals |
| 2025-01-10 | NIPPON ACTIVE VALUE FUND PLC | 15.89% | +0.99pt | may make proposals |
| 2024-12-05 | NIPPON ACTIVE VALUE FUND PLC | 14.90% | +1.02pt | may make proposals |
| 2024-12-02 | NIPPON ACTIVE VALUE FUND PLC | 13.88% | +1.06pt | may make proposals |
| 2024-11-07 | NIPPON ACTIVE VALUE FUND PLC | 12.82% | +1.00pt | may make proposals |
| 2024-10-16 | NIPPON ACTIVE VALUE FUND PLC | 11.82% | +1.02pt | may make proposals |
Cross-shareholdings
From the annual report's status of shareholdings- Listed strategic holdings
- — issues
- Book value
- —
- Sold in the year
- — — issues
- Bought in the year
- — — issues
- Mutual, both reports
- 15
- Held by listed cos.
- 15
| Holds | Book value | Shares vs. prior year | Mutual |
|---|---|---|---|
| Mitsubishi UFJ Financial Group, Inc. 8306 | ¥3,104m | 0.0% | stated |
| OSAKA SODA CO.,LTD. 4046 | ¥2,099m | 0.0% | both reports |
| Inabata&Co.,Ltd. 8098 | ¥1,553m | 0.0% | both reports |
| ZERIA PHARMCEUTICAL CO., LTD. 4559 | ¥820m | 0.0% | both reports |
| Mebuki Financial Group,Inc. 7167 | ¥739m | 0.0% | both reports |
| Sumitomo Mitsui Financial Group, Inc. 8316 | ¥693m | 0.0% | stated |
| Iyogin Holdings,Inc. 5830 | ¥551m | 0.0% | both reports |
| TODA CORPORATION 1860 | ¥408m | 0.0% | both reports |
| The Toho Bank, Ltd. 8346 | ¥387m | 0.0% | both reports |
| Takeda Pharmaceutical Company Limited 4502 | ¥283m | 0.0% | both reports |
Held by: Takeda Pharmaceutical Company Limited 4502, ZERIA PHARMCEUTICAL CO., LTD. 4559, OSAKA SODA CO.,LTD. 4046, Mebuki Financial Group,Inc. 7167, The Toho Bank, Ltd. 8346, Iyogin Holdings,Inc. 5830, Inabata&Co.,Ltd. 8098, TODA CORPORATION 1860, YUKI GOSEI KOGYO CO.,LTD. 4531, CAC Holdings Corporation 4725, SANKYU INC. 9065, DAIKIN INDUSTRIES, LTD. 6367 and 4 more
Purposes, all holdings and mutual flags via /v1/companies/4886/cross-holdings. Share changes include stock splits.
Major shareholders
As of fiscal year end 2026-03-31| Shareholder | Shares | Ratio |
|---|---|---|
| 日本マスタートラスト信託銀行株式会社（信託口） | 2,670,000 | 9.40% |
| NIPPON ACTIVE VALUE FUND PLC | 2,399,000 | 8.44% |
| 武田薬品工業株式会社 | 2,204,000 | 7.76% |
| ゼリア新薬工業株式会社 | 1,877,000 | 6.61% |
| STATE STREET BANK AND TRUST COMPANY 505103 | 1,138,000 | 4.00% |
| 株式会社三菱ＵＦＪ銀行 | 1,100,000 | 3.87% |
| NAVF SELECT LLC | 848,000 | 2.98% |
| NOMURA PB NOMINEES LIMITED OMNIBUS MARGIN（CASHPB） | 789,000 | 2.78% |
| individual holder | 707,000 | 2.49% |
| CACEIS BANK,LUXEMBOURG BRANCH/AIF CLIENTS ASSETS | 593,000 | 2.08% |
U.S. funds holding 4886
SEC Form N-PORT, reports to 2026-07-3138 U.S. funds held 1,549,592 shares worth $21.8m.
| Fund | Shares | Value | % of fund | As of |
|---|---|---|---|---|
| DFA INTERNATIONAL SMALL CAP VALUE PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC | 332,000 | $4.5m | 0.031% | 2026-07-31 |
| VANGUARD TOTAL INTERNATIONAL STOCK INDEX FUND VANGUARD STAR FUNDS | 275,859 | $3.7m | 0.001% | 2026-07-31 |
| VANGUARD DEVELOPED MARKETS INDEX FUND VANGUARD TAX-MANAGED FUNDS | 210,005 | $3.0m | 0.001% | 2026-06-30 |
| Avantis International Small Cap Value ETF American Century ETF Trust | 107,800 | $2.0m | 0.010% | 2026-05-31 |
| THE JAPANESE SMALL COMPANY SERIES DFA INVESTMENT TRUST CO | 124,000 | $1.7m | 0.042% | 2026-07-31 |
Up to 25 funds per stock via the API.
Get this as JSON
GET /v1/companies/4886
GET /v1/companies/4886/financials
GET /v1/companies/4886/details
GET /v1/companies/4886/segments
GET /v1/companies/4886/voting
GET /v1/companies/4886/tender-offers
GET /v1/companies/4886/indicators
GET /v1/companies/4886/earnings-releases
GET /v1/events?ticker=4886
GET /v1/companies/4886/trades
GET /v1/companies/4886/cross-holdings
GET /v1/companies/4886/brief